The Valley Desk

NCT04387461 · Interventional trial

Study of CG0070 Given in Combination With Pembrolizumab, in Non-Muscle Invasive Bladder Cancer, Unresponsive to Bacillus Calmette-Guerin

Overall registry status Completed

Phase 2

Conditions Non Muscle Invasive Bladder Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov